Equities
  • Price (USD)10.05
  • Today's Change-0.060 / -0.60%
  • Shares traded221.45k
  • 1 Year change-38.04%
  • Beta--
Data delayed at least 15 minutes, as of Jun 10 2024 18:50 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
4503:TYO since
announced
Transaction
value
Propella Therapeutics IncDeal completed15 Nov 202315 Nov 2023Deal completed-10.20%175.00m
Data delayed at least 20 minutes, as of Jun 10 2024 07:00 BST.

Institutional shareholders

0.01%Per cent of shares held by top holders
HolderShares% Held
LifeSci Fund Management LLCas of 31 Mar 202442.50k0.00%
RhumbLine Advisers LPas of 31 Mar 202437.92k0.00%
Aperio Group LLCas of 30 Apr 202421.25k0.00%
Johnson Investment Counsel, Inc.as of 30 Apr 202417.60k0.00%
GAMMA Investing LLCas of 31 Mar 20242.40k0.00%
ShariaPortfolio, Inc.as of 09 May 20241.84k0.00%
PNC Investments LLCas of 31 Mar 2024307.000.00%
Operose Advisors LLCas of 31 Mar 202490.000.00%
First Horizon Advisors, Inc.as of 31 Mar 202437.000.00%
Envestnet Asset Management, Inc.as of 29 Feb 20240.000.00%
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.